PBR Life Sciences, founded by pharmacist Ayodeji Alaran in 2015, has secured $1 million in pre-seed funding.
This investment, announced on Friday, aims to enhance AI-driven healthcare solutions across Africa, addressing critical gaps in healthcare data accessibility.
Read also: Airtel Nigeria, Mobihealth collaborate to enhance telehealth services for underserved Nigerians
Bridging the data gap
The company’s flagship platform, Versus, utilises anonymised data from pharmacies to provide insights for pharmaceutical companies, enabling better decision-making regarding product performance and market strategies.
RelatedPosts
Alaran, who previously worked with major pharmaceutical firms like GSK and Pfizer, recognised the urgent need for improved healthcare data in Sub-Saharan Africa.
“Being backed by reputable venture capital investors validates the vital need to close the gap of inadequate real-world healthcare big data,” he stated, emphasising the importance of this funding for future growth.
Commitment to inclusivity
PBR Life Sciences focuses on people, not just numbers. The company seeks to involve underrepresented patient populations in clinical trials, ensuring that healthcare solutions take diverse perspectives into account.
This commitment to inclusivity is vital for addressing the unique health challenges of diverse communities across the continent.
The funding round attracted notable investors such as Launch Africa, Microtraction, and Octerra Capital, who expressed confidence in PBR’s potential.
“PBR is set to be a key player in transforming healthcare delivery across the continent,” remarked Uwem Uwemakpan from Launch Africa.
Similarly, Ashim Egunjobi of Octerra Capital highlighted PBR’s innovative technology: “We believe in PBR’s tremendous potential to reshape access to health data across Africa.”
Read also: Smart Applications enhances healthcare in Kenya with new digital system
Expanding horizons
PBR Life Sciences plans to expand into Ghana and Kenya, aiming to replicate its successful model in these markets. As health challenges grow, the demand for data-driven healthcare solutions increases. PBR aims to enhance care and resource allocation by utilising AI and machine learning.
PBR Life Sciences exemplifies the innovation trend in Africa’s healthcare sector. With new capital, the company aims to transform healthcare using big data and AI, focusing on profitability and impact in emerging markets while ensuring every voice is heard.